EICHORCondition: Nasal Airway Obstruction · Sponsor: Aerin Medical
The purpose of this study is to compare the clinical outcomes of the VivAer procedure to functional rhinoplasty and septoplasty surgery for the treatment of nasal airway obstruction (NAO) to establish non-inferiority.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Southern Head and Neck Surgery | Alexander City, Alabama, United States | — |
| ExcelENT | Birmingham, Alabama, United States | — |
| North Alabama ENT | Huntsville, Alabama, United States | — |
| East Alabama ENT | Opelika, Alabama, United States | — |
| Arizona Desert ENT Specialists | Goodyear, Arizona, United States | — |
| Honor Health ENT | Scottsdale, Arizona, United States | — |
| Tucson ENT | Tucson, Arizona, United States | — |
| Cedars Sinai Medical Center | Los Angeles, California, United States | — |
| Alexis Furze, MD Inc | Newport Beach, California, United States | — |
| Sacramento ENT (DaVinci Research) | Roseville, California, United States | — |
| Mercy Medical Group | Sacramento, California, United States | — |
| Breathe Clear Institute | Torrance, California, United States | — |
+ 23 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06922955